It s the solution that counts. 3M skin antiseptic products

Similar documents
3M Tegaderm CHG Chlorhexidine Gluconate I.V. Securement Dressing Description 3M Tegaderm CHG Chlorhexidine Gluconate I.V. Securement Dressing is used

CE A Review of Anti-septic Agents for Pre-operative Skin Preparation

Access Site and Hub Disinfection: In Vitro Testing of a Novel Device

Do you have skin in the game?

ANTISEPTICS CHLORASCRUB SWAB & SWABSTICKS. Long-Lasting, Broad Spectrum Protection for Effective Antisepsis

Best Products for Skin Antisepsis

If viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.

The Impact of Healthcare Associated Infection (HCAI)

EXECUTIVE SUMMARY. DATE: 13 June 2011

Infusion Skills Competency Checklist To be used at annual skills fair or at any other time for IV Competency

Successful IV Starts Revised February 2014

Surgical Skin Antisepsis in Operating Theatres

6/1/2011. Objectives. Reducing the Risk of Surgical Site Infections: What is the evidence?

Surgical Site Infections: the international guidelines for best practices and effective actions

Vascular access in practice: best practice update

LABORATORY SERVICES TECHNICAL PROCEDURE

A Review of Guidelines and Recommendations on the Prevention of Catheter-related Infections

New Medicines Committee Briefing July Minims Povidone Iodine 5% w/v Eye Drops, Solution

Solutions you need to secure and protect

ChloraPrep with Tint Summary of Product Characteristics

Caring for Your Peripherally Inserted Central Catheter (PICC)

If viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.

The University of Toledo Medical Center and its Medical Staff

MANITOBA RENAL PROGRAM

MANITOBA RENAL PROGRAM

Department Policy. Code: D:PC Entity: Fairview Pharmacy Services. Department: Fairview Home Infusion. Manual: Policy and Procedure Manual

Thora-Para catheter drainage systems

PRINCIPLES AND PRACTICES OF ASEPSIS OBJECTIVES

3/26/2014 OBJECTIVES PRINCIPLES AND PRACTICES OF ASEPSIS DEFINING ASEPSIS MEDICAL ASEPSIS PRINCIPLES OF MEDICAL ASEPSIS

Prevention of Central Line-associated Bloodstream Infections (CLA-BSIs) associated with Arterial Catheters

PATIENT PREOPERATIVE & PREINJECTION SKIN PREPARATION

To standardize wound care and prevent infection in compromised patients who have a Berlin Heart Ventricular Assist Device (VAD).

Principles and Practices of Asepsis

Central Line-Associated Infections (CLABSI) Settings Toolkit

Quality ID #76: Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections National Quality Strategy Domain: Patient Safety

Approved IP Products, #844 Addenda I, Approved IP Products List

High Impact Intervention Peripheral intravenous cannula care bundle

Preventing CLABSI & CAUTI Preventive Measures for Central Line Associated Bloodstream Infection & Catheter Associated UTI

MANAGEMENT OF INTRAVASCULAR (IV) LINES AND THERAPY. All GCC Countries

BLOOD CULTURE SPECIMEN COLLECTION. Skills: 40 points. Objectives:

Evidence-Based Recommendations for Intraoperative Prevention of SSI. Intraoperative Antiseptic Skin Preparation of the Patient

Policy Title: Clinical Asepsis Policy Policy Number :19. Effective Date: 6/10/2013 Review Date: 6/10/2016

OBJECTIVES PRINCIPLES AND PRACTICES OF ASEPSIS

ACTIVE INCISION MANAGEMENT: A PLAN FOR PROTECTING YOUR SURGICAL RESULTS, YOUR PATIENTS AND YOUR HOSPITAL.

Emergency clamp should always be readily available in case of accidental catheter fracture

New Strategies to Reduce MRSA in ICUs

ATI Skills Modules Checklist for Central Venous Access Devices

For optimal incision management. The PREVENA Therapy portfolio of closed incision management solutions.

SARASOTA MEMORIAL HOSPITAL

Doc: 1.9. Course: Patient Safety Solutions. Topic: Infection prevention and control. Summary

DISCOVER NEW HORIZONS IN FLUID DRAINAGE. Bringing Safety and Convenience to Fluid Drainage Management

BLOOD CULTURE POLICY FOR PAEDIATRICS

Initial placement 20FR Guidewire PEG kit REORDER NO:

Guide for Use. Apogee Plus Touch Free Intermittent Catheter System

Conwy & Denbighshire NHS Trust. Ymddiriedolaeth GIG Siroedd Conwy a Dinbych Conwy & Denbighshire NHS Trust

Guide for Use. Advance Plus Touch Free Intermittent Catheter System

Policies and Procedures

CARE OF A TUNNELED CATHETER (HICKMAN & BROVIAC ) with a Needleless Connector (MicroClave Clear)

Measure pre-op BG early enough so that if it is unexpectedly high, a plan of action can be control (BG) - initiated [2,11].

Central Venous Access Devices. Stephanie Cunningham Amy Waters

Student Orientation Module #1

MANITOBA RENAL PROGRAM

Guide for Use. Apogee Plus Touch Free Intermittent Catheter System

Initial placement 24FR Pull PEG kit REORDER NO:

Antisepsis Bath and Oral.. Should We Change Practice? DR AZMIN HUDA ABDUL RAHIM

Needle free connectors, port protectors and infection risk today. Giancarlo Scoppettuolo A. Gemelli University Hospital Foundation, Rome

Bloodstream Infections

Achieving Independence. A Guide to Self-Catheterization with the Bard Touchless Plus Intermittent Catheter System

Peninsula Dental Social Enterprise (PDSE)

Allergy Vial Preparations and USP 797. Donald W Aaronson MD JD MPH

Policies and Procedures LPN Additional Competency: Care of Short Term, Tunneled, Implanted Central Venous Catheters

Skin Protection for the critically ill

Hand Hygiene in Focus. MICROSHIELD Product Catalogue

What Ursidae is the most insouciant. Arek Wiktor M.D.

Measure #76: Prevention of Central Venous Catheter (CVC) - Related Bloodstream Infections National Quality Strategy Domain: Patient Safety

Cleaning and Disinfection of Environmental Surfaces

PATIENT CARE PLAN FOR CARE OF PERIPHERAL MIDLINE. Manufacturers specific recommendations should be noted and adhered to by individual practitioners.

Award Matrix HPVC Intravenous Access Devices and Administration Consumables (Effective 1st March 2017)

DRAFT. Caring for Your Central Venous Catheter. For adult patients. Contents

ASEPT Pleural Drainage System

Running head: REDUCING HOSPITAL- ACQUIRED INFECTIONS 1

Fundamentals of Flushing and Locking

TITLE: Preoperative Skin Preparation: A Review of the Clinical Effectiveness and Guidelines

Sterile Technique & IJ/Femoral Return Demonstration

Prevention of Surgical Site Infections: Beyond Core Measures

The University of Chicago Press The Society for Healthcare Epidemiology of America

SAFETY-DELUXE DIAGNOSTIC AND PROCEDURAL TRAYS

Objectives. The Regulatory Aspects of Infection Prevention and Control. NADONA Infection Prevention and Control Webinar Series

Central Venous Catheter Care and Maintenance (includes catheter troubleshooting guide)

Launch Plan. Simple. 3M Tegaderm CHG Dressing Chlorhexidine Gluconate IV Securement Dressing

Surgical Site Infections: Prevention is better than cure

Per-Q-Cath* PICC Catheters with Excalibur Introducer* System

American College of Surgeons Critical Care Review Course 2012: Infection Control

Turning Technology-related Evidence into Optimal Protocols for Line Maintenance

Application Guide for Full-Thickness Wounds

Quality Care in Surgery: Perioperative Standardization

2011 CDC Guidelines for the Prevention of Intravascular Catheter-Associated Infections

STANDARDIZED PROCEDURE REPROGRAMMING AND REFILLING INTRATHECAL BACLOFEN PUMPS and ACCESSING THE CATHETER ACCESS PORT (Adult,Peds)

Direct Intravenous (IV) Medication Administration Procedure

Jo Kuehn, RN, MSN, CPHQ Jenell Westhoven, RN, BSN

Transcription:

It s the solution that counts 3M skin antiseptic products

SoluPrepTM Brand The impact of surgical site infections Surgical site infections (SSIs) are a major burden on healthcare systems, providers and patients. Using 3M SoluPrep Skin Antiseptic Products is one way you can help reduce the risk of surgical site infections. Occur in 2-5% of all patients undergoing inpatient surgery 1 $ Cost on average $20,785 per patient 2 Affect quality of life 3 Lower patient satisfaction 4 Result in 2-11X increased risk of mortality 1 Increase length of stay by 7-11 days1 Increase nursing care 4 Approximately 5X as likely to result in readmission 5 Advantages of 3M SoluPrep Brand 3M SoluPrep Brand Products help protect patients against microorganisms and reduce the risk of infections 3M SoluPrep Brand was the 1 st skin antiseptic authorized in Canada for Professional Healthcare Use 6 Used by healthcare professionals over 1 billion 7 times Multiple formulations and delivery formats 2

3M alcohol-based antiseptic products Available formulations: 2% w/v Chlorhexidine Gluconate (CHG)/70% v/v Isopropyl Alcohol (IPA) QD * Quarter Dose 0.5% w/v Chlorhexidine Gluconate (CHG)/70% v/v Isopropyl Alcohol (IPA) 3M DuraPrep Brand Iodine Povacrylex (0.7% Available Iodine) / 74% w/w Isopropyl Alcohol (IPA) Helping to improve patient outcomes Legend Wipe Swab (small) Swab (large) Sterile applicator Sponge Bottle 3M Duraprep Sterile Applicator Tinted Brown 3M SoluPrep Brand Products 2% w/v CHG and 70% v/v IPA Sterile applicator DIN 02382113 72 hour Features: Authorized for professional healthcare use; control flow; 1 sterile applicator, ** tinted solution, wedge-shaped sponge for ease of application, peel-open package Persistence Tinted 3M SoluPrep Prefilled Sterile ** Applicator with Solution, Tinted, 2% w/v CHG/70% v/v IPA Catalogue ID 100.24 35 ml single unit dose 52 cm x 52 cm (2,704 cm²) 20.47 in x 20.47 in (419.12 in²) 25 pouches / case * Quarter Dose **Applicator is sterile if package is intact 3

Sponges DIN 02404125 Features: Antiseptic-impregnated sponges with tinted or clear solutions, peel-open package Tinted 3M SoluPrep 4 Sponges, Tinted, Catalogue ID 100.25 97 ml (4 sponges) single unit dose 40 cm x 40 cm (1,600 cm²) 15.75 in x 15.75 in (248.0 in²) 4 per pouch 3M SoluPrep 4 Sponges,, Catalogue ID 100.26 97 ml (4 sponges) single unit dose 40 cm x 40 cm (1,600 cm²) 15.75 in x 15.75 in (248.0 in²) 4 per pouch Tinted 3M SoluPrep 2 Sponges, Tinted, Catalogue ID 100.27 50 ml (2 sponges) single unit dose 40 cm x 40 cm (1,600 cm²) 15.75 in x 15.75 in (248.0 in²) 2 per pouch 4

Large swab DIN 02382040 Features: Pre-moistened swab in a tinted or clear solution, peel-open package 3M SoluPrep Large Swab,, Catalogue ID 102.08 5.2 ml (1 swab) single unit dose 20 cm x 20 cm (400 cm²) 7.87 in x 7.87 in (62.0 in²) 10 cartons / case Tinted 3M SoluPrep Large Swab, Tinted, Catalogue ID 102.09 5.2 ml (1 swab) single unit dose 20 cm x 20 cm (400 cm²) 7.87 in x 7.87 in (62.0 in²) 10 cartons / case Small swab DIN 02382040 Features: Flexible handle, pre-moistened swab, clear solution, peel-open package 3M SoluPrep Small Swab,, Catalogue ID 102.03 1.6 ml (1 swab) single unit dose 10 cm x 11 cm (110 cm²) 3.94 in x 4.33 in (17.05 in²) 50 pouches / carton 10 cartons / case 5

Wipes (large and small) DIN 02385708 Features: solution and cost-effective 3M SoluPrep Large Wipe,, Catalogue ID 101.07 1.5 ml (1 wipe) single unit dose 10 cm x 10 cm (100 cm²) 3.94 in x 3.94 in (15.5 in²) 100 pouches / carton 10 cartons / case 3M SoluPrep Small Wipe,, Catalogue ID 101.06 0.65 ml (1 wipe) single unit dose 6 cm x 7 cm (42 cm²) 2.36 in x 2.76 in (6.51 in²) 200 pouches / carton 20 cartons / case Bottles DIN 02240356 Features: Tinted or clear solution 3M SoluPrep 500 ml Bottle,, Catalogue ID 103.15 500 ml single unit dose 88 cm x 90 cm (7,920 cm²) per 100 ml 34.65 in x 35.43 in (1227.6 in²) 500 ml bottle 12 bottles/ case 6

Tinted 3M SoluPrep 500 ml Bottle, Tinted, Catalogue ID 103.25 500 ml single unit dose 88 cm x 90 cm (7,920 cm²) per 100 ml 34.65 in x 35.43 in (1227.6 in²) 500 ml bottle 12 bottles/ case Tinted 3M SoluPrep 225 ml Bottle, Tinted, Catalogue ID 103.26 225 ml single unit dose 88 cm x 90 cm (7,920 cm²) per 100 ml 34.65 in x 35.43 in (1227.6 in²) 255 ml bottle 12 bottles/ case 3M SoluPrep Brand Products QD * 0.5% w/v CHG and 70% v/v IPA Swab DIN 02119803 Features: Flexible handle, pre-moistened swab, clear solution, peel-open package 24 hour Persistence 3M SoluPrep QD * Small Swab,, 0.5% w/v CHG/70% v/v IPA Catalogue ID 102.02 1.6 ml (1 swab) single unit dose 7.6 cm x 7.6 cm (57.76 cm²) 2.99 in x 2.99 in (8.94 in²) 50 pouches / carton 20 cartons / case 7

SoluPrepTM Brand Wipe DIN 02060019 Features: solution and cost-effective 3M SoluPrep QD * Small Wipe,, 0.5% w/v CHG/70% v/v IPA Catalogue ID 101.02 0.65 ml (1 wipe) single unit dose 6.5 cm x 6.5 cm (42.25 cm²) 2.55 in x 2.55 in (6.5 in²) 200 pouches / carton 20 cartons / case Bottles DIN 02116472 Features: Tinted or clear solution 3M SoluPrep QD * 500 ml Bottle,, 0.5% w/v CHG/70% v/v IPA Catalogue ID 103.14 500 ml single unit dose 20 cm x 20 cm (400 cm²) per 6 ml 7.87 in x 7.87 in (61.93 in²) 500 ml bottle 12 bottles/ case Tinted 3M SoluPrep QD * 500 ml Bottle, Tinted, 0.5% w/v CHG/70% v/v IPA Catalogue ID 103.24 500 ml single unit dose 20 cm x 20 cm (400 cm²) per 6 ml 7.87 in x 7.87 in (61.93 in²) 500 ml bottle 12 bottles/ case 8

3M DuraPrep Brand Surgical Solution Iodine Povacrylex (0.7% Available Iodine) / 74% w/w Isopropyl Alcohol 3M DuraPrep Applicator 48 hour Persistence Features: Sterile applicator. Solution dries to a water-insoluble film that resists wash-off by blood and saline challenges, peel-open package Application time: Single pass, paint-on method Intended use: For external topical use as a long-lasting preoperative skin preparation with fast, broad-spectrum activity Brown Catalogue ID 3M DuraPrep Surgical Solution Iodine Povacrylex (0.7% Available Iodine) / 74% w/w IPA 8630C 26 ml single unit dose 38 cm x 76 cm (2.88 m²) 14.96 in x 29.92 in (447.60 in²) 20 pouches / case Brown Catalogue ID 3M DuraPrep Surgical Solution Iodine Povacrylex (0.7% Available Iodine) / 74% w/w IPA 8635C 6 ml single unit dose 20 cm x 25 cm (500 cm²) 7.87 in x 9.84 in (77.44 in²) 50 pouches / case 9

3M aqueous antiseptic products Available formulations: AQ Alcohol Free 2% w/v Chlorhexidine Gluconate (CHG) LD Low Dose 0.05% Chlorhexidine Gluconate (CHG)/4% Isopropyl Alcohol (IPA) 4% w/v Chlorhexidine Gluconate (CHG) 10% Povidone Iodine (PI) Helping to improve patient outcomes Legend Wipe Swab (small) Swab (large) Sterile applicator Sponge Bottle 3M Duraprep Sterile Applicator Tinted Brown 3M SoluPrep Brand Products AQ 2% w/v CHG Sponges DIN 02408430 72 hour Persistence Features: Antiseptic-impregnated sponge with clear solution, peel-open package Application time: 30 sec for pre-injection/pre-vascular catheterization or 4 min for dry and moist sites pre-surgery (incisions). For patients with allergies or sensitivity to alcohol. 3M SoluPrep AQ 4 Sponges, (Alcohol Free), 2% w/v CHG Catalogue ID 100.17 87 ml (4 sponges) single unit dose 20 cm x 20 cm (400 cm²) 7.87 in x 7.87 in (62.0 in²) 4 per pouch 10 Aqueous Low Dose

3M SoluPrep AQ 2 Sponges, (Alcohol Free), 2% w/v CHG Catalogue ID 100.19 32 ml (2 sponges) single unit dose 17 cm x 17 cm (289 cm²) 6.69 in x 6.69 in (44.8 in²) 2 per pouch Swab DIN 02431483 Features: Flexible handle, pre-moistened swab, clear solution, peel-open package Application time: 30 sec for pre-injection/pre-vascular catheterization or 4 min for dry and moist sites pre-surgery (incisions). For patients with allergies or sensitivity to alcohol. 3M SoluPrep AQ Small Swab, (Alcohol Free), 2% w/v CHG Catalogue ID 102.07 1.6 ml (1 swab) single unit dose 5 cm x 6 cm (30 cm²) 1.97 in x 2.36 in (4.65 in²) 50 pouches / carton 10 cartons / case Wipes DIN 02431491 Features: solution and cost-effective Application time: 30 sec for pre-injection/pre-vascular catheterization or 4 min for dry and moist sites pre-surgery (incisions). For patients with allergies or sensitivity to alcohol. Catalogue ID 101.08 3M SoluPrep AQ Wipe, (Alcohol Free), 2% w/v CHG 1.5 ml (1 wipe) single unit dose 5 cm x 5 cm (25 cm²) 1.97 in x 1.97 in (3.88 in²) 100 pouches / carton 10 cartons / case 11

SoluPrepTM Brand 3M SoluPrep Brand Products LD 0.05% w/v CHG Sponges DIN 02072955 24 hour Persistence Features: Antiseptic-impregnated sponge with clear solution, peel-open package. Low chlorhexidine dose formulation for fragile skin. Application time: 4 min. For patients with fragile skin. 3M SoluPrep LD 4 Sponges,, 0.05% w/v CHG Catalogue ID 100.03 87 ml (4 sponges) single unit dose 12.7 cm x 12.7 cm (161.29 cm²) 5 in x 5 in (25.0 in²) 4 per pouch 3M SoluPrep LD 2 Sponges,, 0.05%CHG, 100.08 Catalogue ID 100.08 32 ml (2 sponges) single unit dose 12.7 cm x 12.7 cm (161.29 cm²) 5 in x 5 in (25.0 in²) 2 per pouch Low Dose 12

3M Brand Antiseptic Solution Products 10% PI Sponges NPN 02094541 24 hour Persistence Features: Antiseptic-impregnated sponge with brown solution, Application time: 1 min for pre-injection or 5 min for pre-surgery peel-open package. For external use. For patients allergic/sensitive to chlorhexidine, when aqueous solution is required Brown Catalogue ID 100.12 3M Brand Antiseptic Solution 10% Povidone Iodine 4 Sponges, 10% PI 100 ml (4 sponges) single unit dose 20 cm x 20 cm (400 cm²) 7.87 in x 7.87 in (62.0 in²) 4 per pouch Brown Catalogue ID 100.09 3M Brand Antiseptic Solution 10% Povidone Iodine 2 Sponges, 10% PI 52 ml (2 sponges) single unit dose 20 cm x 20 cm (400 cm²) 7.87 in x 7.87 in (62.0 in²) 2 per pouch 3M SoluPrep Brand Products Antiseptic Skin Cleanser, 4% w/v CHG Sponge DIN 01925202 Feature: Antiseptic-impregnated sponge, peel-open package Application time: Allow cleanser to remain on skin for 2 min before rinsing Intended use: Pre-surgical antimicrobial cleansing. Helps remove oil, dirt and bacteria from skin and helps reduce risk of developing an infection. For use on intact skin. Catalogue ID 100.10 3M SoluPrep Antiseptic Skin Cleansing Sponge, 4% w/v CHG 25 ml single unit dose 1 sponge per shower 13

Guidelines Centers for Disease Control (CDC) Guideline for the Prevention of Intravascular Catheter-Related Infections, 2011 8 Prepare clean skin with a >0.5% chlorhexidine preparation with alcohol before central venous and peripheral arterial catheter insertion & during dressing changes. Category 1A, pg. S4, S11 Ensure catheter site care is compatible with catheter material. Category 1B, pg. S5, S12 Scrub access port with chlorhexidine, povidone iodine, iodophor, or 70% alcohol. Category 1A, pg. S7 Infusion Nurses Society (INS), 2016 9 Standards of Practice For short peripheral, midline, arterial and central venous access device insertion and maintenance, perform skin antisepsis using the preferred skin antiseptic agent of > 0.5% chlorhexidine in alcohol solution. Standard 33 Pg. S65, S66 Standard 44, pg. S82 Acceptable disinfecting agents for needleless connectors include 70% isopropyl alcohol, iodophors, or >0.5% chlorhexidine in alcohol solution. Standard 34, pg. S68 World Health Organization (WHO), 2016 12 Global guidelines for the prevention of surgical site infection Use alcohol-based antiseptic solutions based on chlorhexidine gluconate for surgical site skin preparation. Strong recommendation, low to moderate quality of evidence A meta-analysis of 12 RCTs showed that alcohol-based antiseptic solutions were more effective than aqueous solutions in reducing the risk of SSI. Strong recommendation, low quality of evidence A significant reduction of SSI risk was shown with the use of alcohol-based chlorhexidine gluconate compared with either aqueous povidone-iodine or povidone-iodine in alcohol-based solutions. Strong recommendation, moderate quality of evidence Operating Room Nurses Association of Canada (ORNAC), 2017 13 Standards, guidelines, and position statements for perioperative registered nurses The operative site should be cleansed prior to surgery with a chlorhexidine (CHG)/70% alcohol based solution. Safer Healthcare Now! Prevent Central Line Infections, 2012 10 Chlorhexidine skin antisepsis provides better skin antisepsis than other antiseptic agents such as povidone-iodine solutions. Include chlorhexidine antisepsis in central line checklist. Reduce and possible error by making only chlorhexidine available. This includes the practice of using chlorhexidine antiseptic to swab ports. Prevent surgical site infections. Getting started kit, 2014 11 The antiseptic of for skin preparation should be alcohol-based chlorhexidine instead of povidone-iodine, unless contraindicated. Alcohol-based chlorhexidine antiseptic solutions significantly reduce the likelihood of wound, catheter, and surgical site colonization and maximize the rapidity, potency and duration of bactericidal activity when compared to other solutions. 14

Surgical Skin Prep Decision Guide Patient Assessment Does the patient have any allergies or sensitivities? CHG allergy or sensitivity Iodine allergy or sensitivity Isopropyl alcohol allergy or sensitivity Use iodophor-based product Use CHG-based product Use alcohol-free aqueous based product Is the patient less than 2 months old? N The preferred is a product that is specified by the manufacturer for patients under two months of age. When products contain a warning or caution regarding use in infants less than 2 months old, the perioperative team should collaboratively evaluate risks and benefits of the products and alternatives such as soaps or saline. The goal is to select a safe and effective surgical skin prep to help reduce bacteria that can cause surgical site infection. Use alcohol-based antiseptic unless contraindicated Surgical Site Assessment Intact Skin? Eyes? Ears? Mucous Membranes? N Use alcohol-based antiseptic unless contraindicated If open wound or trauma, no alcohol-based products may be used. Refer to manufacturer s instructions for use. Do not use alcohol-based products Do not use CHG as it can cause corneal damage Use opthalmic Iodine-based product as specified by manufacturer s instructions for eye site procedures Do not use alcohol-based products Do not use CHG as it can cause deafness if in contact with the inner ear Use aqueous-based iodophor product Do not use alcohol-based products CHG should be used with caution. Some CHG products are prohibited for use in genital. See manufacturer s instructions for use. Use aqueous-based iodophor product Surgical Factors Large amount of fluids? (saline and blood) Upright patient position (e.g., shoulder surgery) N N Consider the use of a water-insoluble, film-forming prep Not a factor for prep selection Consider the use of a water-insoluble, film forming antiseptic Not a factor for prep selection Large prep? (bariatric, cardiovascular surgery) Efficacy is linked to treatment. Some antiseptics cover more per applicator than others. Check manufacturer s information. Applying an antiseptic beyond treatment specifications may affect efficacy. Safety Factors Prep with high microbial count? (groin, toes, fingernails, skin folds) Follow manufacturer s instructions for use. Efficacy testing is based on correct application time, method and treatment. Some antiseptics have different application times for both dry and moist body sites. An applicator must be discarded after prepping a higher microbial regardless of any remaining solution. This may require the use of more than one applicator to complete the patient prep. Is the antiseptic flammable? N Additional precautions should be taken to minimize the risk of surgical fire. Follow manufacturer s instructions for use and AORN Guidelines for Perioperative Practice. Follow manufacturer s instructions for use and AORN Guidelines for Perioperative Practice. This guide contains recommendations based on WHO 2016 Global Guidelines for the Prevention of Surgical Site Infection and AORN 2017 Guidelines for Perioperative Practice; it is not intended to be inclusive of all considerations. Always follow manufacturer s instructions for use. 15

Recommendations for use of small volume 3M skin antiseptics 0.5% CHG/70% IPA 2% CHG/70% IPA 2% CHG Aqueous Suggested for use prior to: Insertion of peripheral intravascular catheters 1st alternative 2nd alternative (too much product) 1st 2nd 1st alternative 2nd alternative Insertion of central venous catheters (larger surface coverage required)* 1st (larger surface coverage required)* (larger surface coverage required)* Central line site maintenance 1st alternative 2nd alternative (too much product) 1st 2nd 1st alternative 2nd alternative Percutaneous device insertion (i.e., chest tube, feeding tube) (larger surface coverage required)* 1st (larger surface coverage required)* (larger surface coverage required)* Percutaneous device site maintenance (i.e., chest tube, feeding tube) 1st alternative 2nd alternative (too much product) 1st 2nd 1st alternative 2nd alternative Minor surgical and medical invasive procedures. (i.e., skin biopsy, bone marrow aspirate, paracentesis) Not recommended (larger treatment required) Alternative (assess procedure and treatment required) 1st Alternative (assess procedure and treatment required) Not recommended (larger treatment required) Alternative (assess procedure and treatment required) Alternative (assess procedure and treatment required) Blood culture 1st alternative 2nd alternative (too much product) 1st 2nd 1st alternative 2nd alternative Application Directions Product should be applied with gentle friction using a repeated back-and-forth motion for manufacturer-recommended application time. Dry Time Allow product to air dry completely; dry time can be affected by volume of product, body site, presence or absence of hair, humidity etc. Legend Large Swab Small Swab Wipes * Assessment based on average adult; may be sufficient for pediatrics. References 1. Anderson, D., et al. Strategies to Prevent Surgical Site Infections in Acute Care Hospitals: 2014 Update. Infection Control and Hospital Epidemiology. 2014; 35(6), 605-627. doi:1. Retrieved from http://www.jstor.org/stable/10.1086/676022 doi:1 2. Zimlichman E, Henderson D, Tamir O, et al. Health Care-Associated Infections: A Meta-analysis of Costs and Financial Impact on the U.S. Health Care System. JAMA Internal Medicine, Dec. 9/23, 2013. 173(22), 2042-2044. 3. Whitehouse et al. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiology. 2002; 23(4):183 189. 4. Prevention and treatment of surgical site infection. NICE Clinical Guidelines https://www.nice.org.uk/guidance/cg74/evidence/full-guideline-242005933 Published October 22, 2008. Accessed December 13, 2016 5. Canadian Surgical Site Infection Prevention Audit Month Report. Retrieved from http://www.patientsafetyinstitute.ca/en/toolsresources/pages/ssi-audit-recap-report-2016-12.aspx 6. Health Canada Drug Product Database. Accessed January 1, 2017 7. Based on 3M SoluPrep Brand sales data 8. O Grady NP, Alexander M. Guidelines for the Prevention of Intravascular Catheter-related Infections. Recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC). American Journal of Infection Control 2011; 39:4 (1 Suppl): S1-34. 9. Infusion Nurses Society. 2016. Infusion Nurses Standards of Practice. Journal of Infusion Nursing, 39 (1Supplement):S1-159 10. Safer Healthcare Now! Campaign. How-to Guide: Prevent Central Line Infections. 2012. http://www.patientsafetyinstitute.ca/en/toolsresources/ (Accessed June 25, 2012) 11. Safer Healthcare Now! Prevent Surgical Site Infections. Getting Started Kit. 2014. www.saferhealthcarenow.ca 12. World Health Organization (WHO). Global Guidelines for the Prevention of Surgical Site Infection. 2016. http://www.who.int/gpsc/ssi-prevention-guidelines/en/ (Accessed February 3, 2017). 13. Operating Room Nurses Association of Canada (ORNAC).The ORNAC Standards, Guidelines, and Position Statements for Perioperative Registered Nurse, (13th ed. Pub. April 2017) PDF (English) Available in Canada from 3M Infection Prevention Division 3M Canada P.O. Box 5757 London, Ontario N6A 4T1 Canada 1-800-563-2921 3M.ca/SkinPrep See Warnings, Cautions, and Directions of Use at 3M.ca/Skinprep for information to assist in benefit-risk assessment. Always the read the product label before use. The complete Terms of Market Authorization are available by calling 1-800-364-3577. 3M, 3M Science. Applied to Life., Soluprep and Duraprep are trademarks of 3M. Used under license in Canada. 2018, 3M. All rights reserved. 1711-10445 E BA-18-25029